Yuliya Demydchuk

Yuliya Demydchuk is a highly experienced scientist currently serving as Principal Scientist in Platform Technology at Bicycle Therapeutics since July 2022 and as Senior Scientist at Bicycle Tx Ltd since January 2018. With a long history at GSK, starting in October 2009, Yuliya has focused on antibody library design, phage display, and high throughput screening. Previous roles include Consultant Analyst at Oakland Innovation, where Yuliya conducted secondary and primary research, as well as Research Associate at the University of Cambridge, specializing in natural product research and biosynthesis of antibiotics. Yuliya also worked as Postdoctoral Research Scientist at the High National School of Applied Biology of Nutrition and as Research Scientist at the Leibniz Institute for Natural Product Research, contributing to various significant projects in natural products and metabolism.